Clinical Trial Update: A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection [Phase 3]

View source ↗

Summary

Phase IIIb trial comparing entecavir plus tenofovir to adding adefovir to continuing lamivudine in lamivudine-resistant chronic hepatitis B; the study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Epivir (Lamivudine)
• Hepsera (adefovir dipivoxil)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 3 | Status: TERMINATED | Results posted: 2010-08-10